Joey, my oldest child, is six years old and already quite a clever creator. He can make houses out of sticks and boats out of cardboard boxes. He can build an entire city with toy blocks and crafty cabins with the same Lincoln Logs his daddy used more than 30 years ago. Most recently, Joey has been sharpening his skills with Lego.

Today, while his daddy built him a Lego jet, Joey constructed his own masterpiece. He called it his Cancer Center.

I wasn't around to hear Joey dedicate his building to such an important cause. But I heard about it after the fact when Joey offered me a mini-tour of the structure. I learned that the center has a helicopter landing pad and offices with windows for the employees. I was shown an emergency vehicle with its own system for taking blood from patients, rendering it healthy, and then returning it to the body. And then just as I wanted more -- more details, more specifics, more history on just why he built this cancer center -- Joey's attention moved elsewhere. And so I know nothing more about the cancer center sitting in the playroom of my house.

Cancer is no strange topic for Joey who has been along on my own cancer ride for the past two years -- so perhaps I am the inspiration for his architectural creation. But I suspect the real driving force behind Joey's latest project is the vacant land we passed yesterday. This land is the future site of a new cancer center in our city, and Joey probably heard me talking about the ground breaking ceremony that just took place. Regardless, cancer was on his mind this morning. And while the topic may be far from his mind now -- and I'm sure the building will be demolished by the day's end -- I am touched that for mere moments, Joey was invested in a noble cancer endeavor.

St. Jude Children's Research Hospital scientists have demonstrated a new locally applied treatment for the eye cancer retinoblastoma. The new treatment, tested on mice, reduced the size of the tumor and also did not cause the side effects common with chemotherapy.

This targeted therapy uses a customized drug to disable a specific molecule inside a growing cancer cell. It is delivered locally to the site of the disease, rather than using systematic treatment. Dr. Dyer, Ph. D., associate member of the St. Jude Department of Developmental Neurobiology said "The findings suggest that this treatment not only could offer children with retinoblastoma more effective and less toxic treatment, it could also increase the chance that their vision can be preserved by eliminating the tumor and preventing its spread from the eye to the rest of the body".

Retinoblastoma occurs in about 5,000 young children worldwide each year, arising from the immature retina, which is the part of the eye responsible for detecting light and color. A report on this work appears in the November 2nd issue of the journal Nature.

Originally designed by the military as a high-tech way to see in the dark, thermography has become a painless, radiation-free, non-invasive procedure able to detect the earliest signs of breast cancer. Thermography maps out temperatures on the skin's surface, and the infrared images can pick up subtle differences that can indicate vascular changes that signal a cancer in the beginning stages. Not only that, but it can be used to monitor the breasts during treatment to track progress of breast cancer. According to the Thermography website, thermography is designed to detect fast-growing, active tumors in the intervals between mammography screenings or when mammography is not indicated by screening guidelines for women under 50 years of age -- and is particularly useful for women under 50 where mammography is less effective. Hypothetically, if there is an ability to track the slightest changes in tumor growth or regression -- choices in treatment could expand to include more alternative therapies with less guess work. Regardless of treatment choices -- alternative therapies or conventional medicine or a combination of both --there would be less wait time in finding out if a cancer treatment is working.